Tuberc Respir Dis > Volume 53(6); 2002 > Article
Tuberculosis and Respiratory Diseases 2002;53(6):656-661.
DOI: https://doi.org/10.4046/trd.2002.53.6.656    Published online December 1, 2002.
A Case of Amiodarone-Induced Pulmonary Toxicity After a Long Course of a Low Dose Therapy.
Jung Il Ryu, Wan Suk Lee, Dae Sung Hyun, Sang Chae Lee, Tae Rim Shin
Department of Internal Medicine, College of Medicine, Catholic University of Daegu, Daegu, Korea. trshin@cuth.cataegu.ac.kr
Abstract
Amidarone is one of the most commonly prescribed anti-arrythmic agents for almost all arrythmias, whether atrial or ventricular in origin. There are several side effects associated with amiodarone therapy. These include corneal deposits, abnormal liver function tests, hyper and hypothyroidism, bluish discolorations of the skin, bone marrow suppression, coagulopathies, peripheral neuropathies, and pulmonary toxicity. Amiodarone-induced pulmonary toxicity(APT), which was first described in 1980, is potentially serious side effects that are believed to develop in 5% of patients. Doctors often assume that APT occurs only when high amiodarone doses are used for a long time, but in practice a low maintenance dose of amiodarone may also be toxic. In this report, a case of amiodarone-induced pulmonary toxicity after a long course of a low dose therapy for refractory supraventricular arrythmia is described.
Key Words: Amiodarone, Pulmonary toxicity


ABOUT
ARTICLE & TOPICS
Article category

Browse all articles >

Topics

Browse all articles >

BROWSE ARTICLES
FOR CONTRIBUTORS
Editorial Office
101-605, 58, Banpo-daero, Seocho-gu (Seocho-dong, Seocho Art-Xi), Seoul 06652, Korea
Tel: +82-2-575-3825, +82-2-576-5347    Fax: +82-2-572-6683    E-mail: katrdsubmit@lungkorea.org                

Copyright © 2024 by The Korean Academy of Tuberculosis and Respiratory Diseases. All rights reserved.

Developed in M2PI

Close layer
prev next